跳至主要内容
临床试验/CTRI/2024/08/073094
CTRI/2024/08/073094尚未招募3 期

Effectiveness of Individualized Homoeopathic Medicine in the Management of Psoriatic Arthritis by using DAPSA Score – A Prospective Clinical Interventional Study

Dr Anusree P B1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2024年9月11日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
35
试验地点
1
主要终点
Changes in DAPSA score baseline, 3

研究概览

简要总结

This study is an open label, single arm, clinical interventional study to determine the effectiveness of individualized homoeopathic medicines in the management of psoriatic arthritis by using DAPSA score that will be conducted in OPD, IPD, and peripheral units of department of practice of medicine at National Homeopathy Research  Institute in mental health , kottayam , The primary outcome measure will be assessed using DAPSA score on baseline, 3rd, 6th, 9th and 12th month . The secondary outcome measures will be PASI and HAQ - DI .  The changes in severity of skin lesions in psoriasis using PASI  will be assessed on baseline, 3rd, 6th, 9th and 12th month. The evaluation of disability using HAQ-DI  will be assessed on baseline, 6th and 12th month. As the study with the aforementioned domains is one of its kind , it aims to make the efforts to offer possibilities for future research in the effectiveness of Individualized Homoeopathic Medicine in the management of psoriatic arthritis in general .

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients in the age group of 18-65 years and of both genders.
  • Patients who fulfil the CASPAR criteria.

排除标准

  • Patients with known conditions such as gout, osteoarthritis, rheumatoid arthritis, etc., Patients having known severe structural deformity.
  • Pregnant and lactating women.
  • Patients with known advanced systemic illness.

结局指标

主要结局

Changes in DAPSA score baseline, 3

时间窗: Baseline, 3rd, 6th, 9th and 12th month.

rd, 6th, 9th and 12th month for interpreting the

时间窗: Baseline, 3rd, 6th, 9th and 12th month.

disease activity in psoriatic arthritis.

时间窗: Baseline, 3rd, 6th, 9th and 12th month.

次要结局

  • Changes in the severity of skin lesions in psoriasis using PASI - baseline, 3rd, 6th, 9th & 12th month(Evaluation of disability using HAQ – DI baseline, 6th month & 12th month)

研究者

发起方
Dr Anusree P B
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Anusree P B

National Homoeopathy Research Institute in Mental Health, Kottayam

研究点 (1)

Loading locations...

相似试验